A significant collaboration has been announced between 9amHealth, a prominent leader in complete cardiometabolic care, and Mark Cuban Cost Plus Drug Company, PBC (Cost Plus Drugs). This partnership aims to dramatically enhance the affordability and accessibility of obesity medications for employers across the nation, alongside providing comprehensive, expert-led, whole-body care within employer benefit plans.

The core of this collaboration lies in 9amHealth's strategy to leverage low-cost oral medications from Cost Plus Drugs as a vital option for treating obesity, all under a clinically validated prescribing protocol. Beyond this, 9amHealth's specialized obesity program for self-insured employers also incorporates branded obesity GLP-1 medications, offered at transparent monthly costs through direct partnerships with manufacturers. This dual approach from the two companies presents a complete and cost-efficient solution for employers looking to broaden their coverage for weight management and associated chronic conditions such as diabetes, high cholesterol, and hypertension.

This alliance is particularly timely, as patient demand for weight-loss medications is skyrocketing and medical costs continue to surge. The collaboration effectively combines Cost Plus Drugs' groundbreaking transparent pricing model with 9amHealth's high-touch, comprehensive care. Employees will now gain access to high-quality, low-cost medications from Cost Plus Drugs, complemented by the expertise of 9amHealth's Care Team. This team comprises Obesity Medicine physicians, endocrinologists, and cardiometabolic specialists, all available without the typical long waiting periods or expensive appointments.

Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company, expressed enthusiasm for the collaboration, emphasizing their shared mission to make prescription drugs more affordable and their unwavering commitment to transparent drug pricing, especially for patients with cardiometabolic conditions. Paul Geevarghese, COO and Co-Founder of 9amHealth, highlighted that the collaboration not only drastically lowers medication costs but also connects members to genuine human care, including specialists in obesity and diabetes, clinical pharmacists, and continuous nutritional support from registered dietitians—all accessible conveniently from home.

Key benefits for employers integrating this solution include virtual medical care provided by 9amHealth's expert Care Team, access to first-generation obesity medications at transparent and discounted prices via costplusdrugs.com, and coverage for branded obesity GLP-1s at fixed monthly costs through 9amHealth's manufacturer programs. Additional advantages encompass at-home lab testing, prescription delivery services, and 24/7 clinical support. This scalable solution is designed to efficiently manage obesity, diabetes, and related chronic conditions across employer populations.

9amHealth, established in 2021 by the team behind mySugr, delivers a first-of-its-kind, whole-body approach to preventing and treating cardiometabolic conditions. They partner with employers, health plans, and PBMs, ensuring members receive personalized care plans, prescription delivery, at-home lab tests, and unlimited specialist access. Mark Cuban Cost Plus Drug Company, a public-benefit corporation launched its online pharmacy in January 2022, offering over 2,300 prescription products with a transparent, standard markup, fundamentally aiming to transform the pharmaceutical industry. This powerful collaboration answers the growing need for clinically effective and financially sustainable weight-loss coverage in the current healthcare landscape.